These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10100412)

  • 1. Current controversies in screening: cholesterol, breast cancer, and prostate cancer.
    Sox HC
    Mt Sinai J Med; 1999 Mar; 66(2):91-101. PubMed ID: 10100412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
    Howard K; Barratt A; Mann GJ; Patel MI
    Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer screening. Interpreting new data for clinical practice.
    Daly L
    Physician Assist; 1994 Oct; 18(10):47-51, 56, 61-6. PubMed ID: 10138304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chances and risks of prevention in elderly people for the three major cancers: breast-, prostate- and colorectal cancers].
    Kolb GF
    Zentralbl Gynakol; 2006 Jun; 128(3):123-8. PubMed ID: 16758377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial results did not resolve controversies surrounding prostate cancer screening.
    Hoffman RM
    Curr Opin Urol; 2010 May; 20(3):189-93. PubMed ID: 20224414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening mammography controversies: resolved, partly resolved, and unresolved.
    Feig SA
    Breast J; 2005; 11 Suppl 1():S3-6. PubMed ID: 15725113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is routine mammography screening appropriate for women 40-49 years of age?
    Miller AB
    Am J Prev Med; 1991; 7(1):55-62. PubMed ID: 1867901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor screening with special reference to breast and prostate carcinoma].
    Jost LM
    Ther Umsch; 1997 Aug; 54(8):439-50. PubMed ID: 9381414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for breast and prostate cancer: a survey of Texas primary care physicians.
    Kripalani S; Weinberg AD; Cooper HP
    Tex Med; 1996 Dec; 92(12):59-67. PubMed ID: 8979762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer screening for women aged 40 to 49 years--what does the evidence mean for New Zealand?
    Baker S; Wall M; Bloomfield A
    N Z Med J; 2005 Aug; 118(1221):U1628. PubMed ID: 16138166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?
    Tudiver F; Guibert R; Haggerty J; Ciampi A; Medved W; Brown JB; Herbert C; Katz A; Ritvo P; Grant B; Goel V; Smith P; O'Beirne M; Williams JI; Moliner P
    J Fam Pract; 2002 Sep; 51(9):760. PubMed ID: 12366894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gothenburg Breast Screening Trial.
    Bjurstam N; Björneld L; Warwick J; Sala E; Duffy SW; Nyström L; Walker N; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Salander H; Säve-Söderbergh J; Wahlin T
    Cancer; 2003 May; 97(10):2387-96. PubMed ID: 12733136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of PSA screening. Early detection of prostate cancer.
    Pickles T
    Can Fam Physician; 2004 Jan; 50():57-63. PubMed ID: 14761105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.